Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ADIL
$4.86
-6.72%
ADIL
· Adial Pharmaceuticals, Inc.
$4.86
-0.35 (-6.72%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.13M
Shares
2.63M
All earnings calls
Earnings call · FY2022 Q3
Adial Pharmaceuticals, Inc. (ADIL) Q3 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$75.50
Net income
-$3.11M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 15, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2022 · complete as-filed document